Benjamin F. Edwards & Company’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$3K Sell
80
-102
-56% -$3.83K ﹤0.01% 2011
2024
Q1
$8K Buy
+182
New +$8K ﹤0.01% 1762